Literature DB >> 20188092

Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.

Anil Kachroo1, Michael C Irizarry, Michael A Schwarzschild.   

Abstract

Environmental exposures suspected of contributing to the pathophysiology of Parkinson's disease (PD) include potentially neurotoxic pesticides, which have been linked to an increased risk of PD. Conversely, possible protective factors such as the adenosine antagonist caffeine have been linked to a reduced risk of the disease. Here we assessed whether caffeine alters dopaminergic neuron loss induced by exposure to environmentally relevant pesticides (paraquat and maneb) over 8weeks. The number of nigral neurons positive for tyrosine hydroxylase immunoreactivity (TH+) was assessed using stereological methods and found to be significantly reduced (to 60% of control) by combined pesticide treatment. Caffeine at 20mg/kg significantly reduced TH+ neuron loss (to 85% of the respective control). The results demonstrate the neuroprotective potential of caffeine in a chronic pesticide exposure model of model of PD. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188092      PMCID: PMC2864327          DOI: 10.1016/j.expneurol.2010.02.007

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  47 in total

Review 1.  Genetic and environmental factors in the pathogenesis of Parkinson's disease.

Authors:  Y Mizuno; S Shimoda-Matsubayashi; H Matsumine; N Morikawa; N Hattori; T Kondo
Journal:  Adv Neurol       Date:  1999

Review 2.  Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease.

Authors:  Kui Xu; Elena Bastia; Michael Schwarzschild
Journal:  Pharmacol Ther       Date:  2004-12-21       Impact factor: 12.310

3.  Pesticide exposure and risk for Parkinson's disease.

Authors:  Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

4.  Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.

Authors:  Jordi Bové; Jordi Serrats; Guadalupe Mengod; Roser Cortés; Eduardo Tolosa; Concepció Marin
Journal:  Exp Brain Res       Date:  2005-06-21       Impact factor: 1.972

5.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.

Authors:  Francesco Fornai; Oliver M Schlüter; Paola Lenzi; Marco Gesi; Riccardo Ruffoli; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Fabrizio Pontarelli; Giuseppe Battaglia; Antonio Pellegrini; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

6.  Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats.

Authors:  Martine Saint-Pierre; Marie-Eve Tremblay; Attila Sik; Robert E Gross; Francesca Cicchetti
Journal:  J Neurochem       Date:  2006-08       Impact factor: 5.372

7.  Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.

Authors:  A I Brooks; C A Chadwick; H A Gelbard; D A Cory-Slechta; H J Federoff
Journal:  Brain Res       Date:  1999-03-27       Impact factor: 3.252

8.  Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  O Suchowersky; G Gronseth; J Perlmutter; S Reich; T Zesiewicz; W J Weiner
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

9.  KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse.

Authors:  Mette Pierri; Elisabetta Vaudano; Thomas Sager; Ulrica Englund
Journal:  Neuropharmacology       Date:  2005-03       Impact factor: 5.250

10.  Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence.

Authors:  Mohammad Taghi Joghataie; Mehrdad Roghani; Fereidoun Negahdar; Leila Hashemi
Journal:  Parkinsonism Relat Disord       Date:  2004-12       Impact factor: 4.891

View more
  29 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease.

Authors:  Patricia K Sonsalla; Lai-Yoong Wong; Suzan L Harris; Jason R Richardson; Ida Khobahy; Wenhao Li; Bharathi S Gadad; Dwight C German
Journal:  Exp Neurol       Date:  2012-01-28       Impact factor: 5.330

3.  Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.

Authors:  Anil Kachroo; Michael A Schwarzschild
Journal:  Brain Res       Date:  2014-03-26       Impact factor: 3.252

Review 4.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

5.  Differential Effect of Caffeine Consumption on Diverse Brain Areas of Pregnant Rats.

Authors:  Inmaculada Ballesteros-Yáñez; Carlos Alberto Castillo; Mariano Amo-Salas; José Luis Albasanz; Mairena Martín
Journal:  J Caffeine Res       Date:  2012-06

6.  Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease.

Authors:  Anil Kachroo; Michael A Schwarzschild
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

7.  Autophagy inhibition by caffeine increases toxicity of methamphetamine in SH-SY5Y neuroblastoma cell line.

Authors:  Rujiraporn Pitaksalee; Yupin Sanvarinda; Theerin Sinchai; Pantip Sanvarinda; Anusorn Thampithak; Nattinee Jantaratnotai; Surawat Jariyawat; Patoomratana Tuchinda; Piyarat Govitrapong; Pimtip Sanvarinda
Journal:  Neurotox Res       Date:  2015-01-15       Impact factor: 3.911

Review 8.  Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Authors:  Pamela Lopert; Manisha Patel
Journal:  J Neural Transm (Vienna)       Date:  2015-03-07       Impact factor: 3.575

9.  Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.

Authors:  Sharawan Yadav; Satya Prakash Gupta; Garima Srivastava; Pramod Kumar Srivastava; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2011-12-27       Impact factor: 3.996

Review 10.  Pesticide exposure and neurodevelopmental outcomes: review of the epidemiologic and animal studies.

Authors:  Carol J Burns; Laura J McIntosh; Pamela J Mink; Anne M Jurek; Abby A Li
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2013       Impact factor: 6.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.